Skip to main content

Table 2 Indications for pharmacologic stress echo

From: Assessment of dipyridamole stress echocardiography for risk stratification of diabetic patients

Indications 483 -N(%) 264 - N(%)
Routine clinical and imaging follow-up 123 (25 %) 72 (27 %)
Thoracic pain 107 (22 %) 58 (22 %)
Perioperative risk stratification 76 (15 %) 41 (15 %)
Evaluation of known coronary artery disease 69 (14 %) 37 (14 %)
Altered resting EKG 30 (6 %) 19 (7 %)
Dyspnea/fatigue 18 (4 %) 12 (4 %)
Altered/insufficient exercise stress testing (N/%) 132 (27 %) 70 (26 %)